Another day, another drugmaker getting yelled at

By Robert King

Published February 14, 2017 5:01am ET

Another day, another drugmaker getting yelled at — Rep. Elijah Cummings, shown, and Sen. Bernie Sanders, I-Vt., expressed outrage that Marathon Pharmaceuticals planned to charge $89,000 a year for a drug that's widely available abroad for about $1,000 a year. (AP Photo/Manuel Balce Ceneta, File) | Manuel Balce Ceneta

Outrage is brewing in Congress over another drugmaker that raised the price of a drug for a rare disease.

Lawmakers are demanding answers about the costs of research and development and how much revenue and profit the company stands to gain from drug. A congressional hearing with company officials could be on the horizon.

Print subscriber? Click here to login/register your account

Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Another day, another drugmaker getting yelled at

Recommended Stories

GOP lawmaker calls for FCC inquiry into outlets that reported on fabricated Wedgewood polling

Will Serbia elections break Vucic’s grip on power?

Treasury traces SPLC to debanking of Christians after group dismissed it as conspiracy

Full midterm coverage.Deeper analysis.

Tag: